
| Serial Number | 99113144 |
| Word Mark | ASCENTAGE |
| Filing Date | Monday, March 31, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 10, 2026 |
| Description of Mark | The mark consists of the word Ascentage in a stylized font with two arc-shaped lines appearing above and underneath the first "A", and the center line of the first "A" appearing as a diagonal line extending above the letters "sce" of Ascentage. |
| Goods and Services | Chemical preparations for medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures for medical purposes; medicated sweets; dietetic preparations adapted for medical purposes; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 31, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ASCENTAGE PHARMA (SUZHOU) CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | JIANGSU 215000 CN |
| Party Name | ASCENTAGE PHARMA (SUZHOU) CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | JIANGSU 215000 CN |
| Event Date | Event Description |
| Monday, March 31, 2025 | NEW APPLICATION ENTERED |
| Monday, March 31, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 14, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, August 28, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, September 10, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 10, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 10, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 5, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 5, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 5, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 12, 2026 | SUSPENSION LETTER WRITTEN |
| Monday, January 12, 2026 | LETTER OF SUSPENSION E-MAILED |
| Monday, January 12, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, February 11, 2026 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, February 11, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 11, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 12, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 4, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 10, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 10, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |